The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 349:1227-1235 September 25, 2003 Number 13
NextNext

Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
Philip S. Wells, M.D., David R. Anderson, M.D., Marc Rodger, M.D., Melissa Forgie, M.D., Clive Kearon, M.D., Ph.D., Jonathan Dreyer, M.D., George Kovacs, M.D., Michael Mitchell, M.D., Bernard Lewandowski, M.D., and Michael J. Kovacs, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set

Commentary
-Perspective
 by Bockenstedt, P.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
ABSTRACT

Background Several diagnostic strategies using ultrasound imaging, measurement of D-dimer, and assessment of clinical probability of disease have proved safe in patients with suspected deep-vein thrombosis, but they have not been compared in randomized trials.

Methods Outpatients presenting with suspected lower-extremity deep-vein thrombosis were potentially eligible. Using a clinical model, physicians evaluated the patients and categorized them as likely or unlikely to have deep-vein thrombosis. The patients were then randomly assigned to undergo ultrasound imaging alone (control group) or to undergo D-dimer testing (D-dimer group) followed by ultrasound imaging unless the D-dimer test was negative and the patient was considered clinically unlikely to have deep-vein thrombosis, in which case ultrasound imaging was not performed.

Results Five hundred thirty patients were randomly assigned to the control group, and 566 to the D-dimer group. The overall prevalence of deep-vein thrombosis or pulmonary embolism was 15.7 percent. Among patients for whom deep-vein thrombosis had been ruled out by the initial diagnostic strategy, there were two confirmed venous thromboembolic events in the D-dimer group (0.4 percent; 95 percent confidence interval, 0.05 to 1.5 percent) and six events in the control group (1.4 percent; 95 percent confidence interval, 0.5 to 2.9 percent; P=0.16) during three months of follow-up. The use of D-dimer testing resulted in a significant reduction in the use of ultrasonography, from a mean of 1.34 tests per patient in the control group to 0.78 in the D-dimer group (P=0.008). Two hundred eighteen patients (39 percent) in the D-dimer group did not require ultrasound imaging.

Conclusions Deep-vein thrombosis can be ruled out in a patient who is judged clinically unlikely to have deep-vein thrombosis and who has a negative D-dimer test. Ultrasound testing can be safely omitted in such patients.


Source Information

From the Departments of Medicine, Radiology, and Emergency Medicine, Ottawa Hospital, University of Ottawa, Ottawa, Ont. (P.S.W., M.R., M.F., B.L.); Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, N.S. (D.R.A., G.K., M.M.); London Health Sciences Centre, University of Western Ontario, London, Ont. (J.D.); and Henderson Hospital, McMaster University, Hamilton, Ont. (C.K.) — all in Canada.

Address reprint requests to Dr. Wells at Ottawa Hospital Civic Campus, Suite F647, 1053 Carling Ave., Ottawa, ON K1Y 4E9, Canada, or at pwells{at}ohri.ca.

Full Text of this Article


Related Letters:

D-Dimer in Venous Thromboembolism
Stern S. D., Propp D. A., Kumar A. M., Vayssairat M., de Clari L., Wells P. S., Anderson D.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:192-194, Jan 8, 2004. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.